Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIGTS: Medical Treatment vs Filtration Surgery for Open-Angle Glaucoma
NCT00000149Phase 3Unknown
- Sponsor
- National Eye Institute
- Start
- Oct 1993
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of carvedilol in open-angle glaucoma (OAG) (2 arms), sponsored by National Eye Institute. Primary endpoints: Intraocular Pressure at 24 months, Visual Field Evaluation at 24 months and 1 more. Status: unknown.
02
Drugs
carvedilol
03
Conditions
open-angle glaucoma (OAG)
Beyond the preview
Go deeper on NCT00000149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000149.